Clinical Trials Browser

Phase 1 × Recurrence × ixazomib × Clear all

NCT00932698 2019-08-07

Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma

Phase 1 Completed

60 enrolled 34 charts

Multiple Myeloma, Recurrence